Aevi Genomic Medicine, Inc. (GNMX)

[Twocan]

• Thinly traded nano cap Aevi Genomic Medicine (GNMX +12.5%) jumps on a 9x surge in volume in apparent response to Form 4 filings after the close yesterday disclosing stock purchases by insiders.
• CEO Michael Cola: 119,047 shares at $1.26.
• CSO Garry Neil, M.D.: 75,000 shares at $1.26.
• Director Eugene Bauer: 19,841 shares at $1.26.
• Director Alastair Clemow: 19,841 shares at $1.26.
• Director Barbara Duncan: 59,524 shares at $1.26.
• Director Wilbur Gantz: 39,683 shares at $1.26.
• Director Joseph Grano: 39,683 shares at $1.26.
• Director Sol Barer: 421,032 shares at $1.26.